Introduction
============

Peritoneal adhesions, or bands of fibrous tissue connecting abdominal organs, are clinical complications caused by a wide variety of diseases and disorders. They are most common after abdominal surgery and are the leading cause of postoperative intestinal obstruction ([@B01]) and peritonitis ([@B02]). Attempts at preventing adhesions have included improving surgical techniques ([@B03]); reducing serosal injury; using anticoagulants such as heparin to prevent fibrin deposition ([@B04],[@B05]), hyaluronidase and streptokinase to remove fibrin exudation ([@B06]), or dexamethasone to inhibit fibroblastic growth; and applying sodium carboxymethyl cellulose (SCMC) ([@B07]). However, none of these methods effectively prevent peritoneal adhesions under all surgical conditions, and the incidence of postoperative abdominal adhesions is still very high ([@B02]).

Adhesion formation may be caused by abrasions between injured portions of the peritoneum, and the insertion of a barrier between segments of peritoneum can effectively prevent it ([@B08]). Thus, development of an effective, nontoxic, and bioreabsorbable material for adhesion prevention has become an important research goal ([@B09]-[@B13]). Local application of barrier agents such as SCMC has been shown to reduce the formation of adhesions in rats and humans, and it has been approved for clinical use ([@B14],[@B15]).

SCMC acts as an effective anti-adhesion agent by providing a mechanical barrier. A polysaccharide derivative, it is nontoxic, nonimmunogenic, nonpyrogenic, nonhemolytic, nonteratogenic, nonmutagenic, biodegradable, bioabsorbable, biocompatible ([@B16],[@B17]), and can be made into solutions and gels. Specifically, SCMC forms a protective membrane on the serosal surface, prevents the migration of cells including inflammatory cells, reduces fibroblast viability and proliferation, inhibits decreased fibrolytic activity, and prevents fibrin deposition on the injured peritoneum during peritoneal repair ([@B18]-[@B21]).

The glucocorticoid hormone dexamethasone strongly inhibits inflammation induced by a variety of physical, chemical, and immunological causes. In the early phases of inflammation, dexamethasone can reduce exudation, edema, capillary dilation, leukocyte infiltration, and phagocytic reaction. In the late phases of inflammation, it can inhibit capillary proliferation and fibroblastic proliferation, reduce the formation of granulation tissues, and prevent adhesion and scar formation. To avoid the loss of dexamethasone in the wound due to accumulation of blood and body position, dexamethasone may be mixed with SCMC, which has a synergic effect on adhesion prevention.

Material and Methods
====================

Animals
-------

A total of 160 male and female Wistar rats (3 months old, 220±40 g) were obtained from the animal center at the School of Medicine, Jinlin University, China. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the No. 1 Hospital of Jilin University, China \[(2013) clinical trial (2013-121)\]. All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.

The rats were randomly assigned to 4 groups (n=40 each) according to treatment: group A, induction of adhesions with no further treatment; group B, induction of adhesions + SCMC; group C1, induction of adhesions + SCMC + 3 mg dexamethasone; and group C2, induction of adhesions + SCMC + 8 mg dexamethasone.

Surgical technique
------------------

We used the adhesion induction model previously described by Tarhan et al. ([@B22]). Rats were anesthetized with an intraperitoneal injection of 100 mg/L chloral hydrate (250 mg/kg body weight; HeChang Company, China). A 4-cm midline incision was made in the abdomen, and the abdominal cavity was opened to expose the ileocecal junction. At the mesenteric border, the ileocecal junction was rubbed with dry sterile gauze to make a 1.0×8.0 cm lesion. This was repeated approximately 10 times at the same area until hemorrhage points appeared. Care was taken to avoid damaging other tissues. For group A, no additional treatment was applied. For group B, 3 mL SCMC (provided by the Changchun Institute of Applied Chemistry, Chinese Academy of Science, China) was applied to the surface of the lesion. For groups C1 and C2, 3 mL SCMC with 3 or 8 mg dexamethasone, respectively, was applied. The abdominal cavity was then closed. After surgery, rats were individually housed and fasted for 10 h.

Twelve days after surgery, all rats were euthanized, and the abdominal adhesions were evaluated. A 2-cm ileocecal junction with adhesions was randomly selected, removed, and embedded in paraffin. The sections were examined under light microscope.

Assessment of adhesions
-----------------------

Abdominal adhesions were assessed by a surgeon blind to the experiments at 7-12 postoperative days, based on a scale described by Leach et al. ([@B23]). This scoring system takes into consideration abdominal adhesion range, extent, and intensity. Scores for the range of adhesions depended on the percent of the lesion area affected and the number of bands or location of adhesions: 0, no adhesion; 1, 1-25% or one band; 2, 26-50% or two bands; 3, 51-75% or more than two bands, and 4, 76-100% or direct adhesions to the abdominal wall. The extent of adhesions was scored 0, 1, 2, or 3 for no adhesions, filmy thickness, dense thickness, and dense thickness with vascularity, respectively. The intensity of adhesions was scored based on the ease of dissection: 0 for no adhesions, 1 for easy tears, 2 for blunt dissection, and 3 for sharp dissection. The final adhesion scores were the sum of the scores for range, extent, and intensity. The maximum score possible was 10.

Statistical analyses
--------------------

Statistical analyses were performed using the SAS 9.0 software (USA). Values are reported as means±SD. Student\'s *t*-tests were performed to identify significant differences between two independent groups. Probability values \<0.05 were considered to be statistically significant.

Results
=======

Postoperative deaths and wound healing
--------------------------------------

Four rats in group A, in which adhesions were experimentally induced and untreated, died 5-8 days after surgery. Two rats in group B, in which adhesions were induced and then treated with 3 mL SCMC only, died 8 days after surgery. Rats in groups C1 and C2 were induced to develop adhesions and treated with 3 mL SCMC mixed with either 3 or 8 mg dexamethasone, respectively. Two rats in each group died 3-4 days after surgery. Thus, the mortality rates were 10, 5, 5, and 5% in groups A, B, C1, and C2, respectively. Autopsies showed that 3 rats in group A and 2 rats in group B died of strangulation necrosis induced by severe bowel adhesions. These rats were assigned total adhesion scores of 10. One rat in group A, 2 rats in group C1, and 2 rats in group C2 died of traumatic shock induced by striped ileum perforation. No adhesions were observed in the rats that died of traumatic shock, and these animals were excluded from the study.

The wound healing rate was 100% for groups A, B, and C1, and 90% for group C2. In group C2, wound healing was delayed in 4 rats.

Evaluation of adhesions
-----------------------

In group A, the adhesions were extensive and dense and vascularized in some of the rats. Blunt or sharp dissection was usually required to separate adhesions. In groups C1 and C2, the adhesions were mild and filmy, and were easily dissected. The adhesions in group B were more severe than those in group A, but milder than those in groups C1 and C2. The mean adhesion score in group C1 (3.38±0.49) was significantly lower than that of group B (6.01±0.57, P\<0.01) and group A (8.01±0.67, P\<0.05; [Table 1](#t01){ref-type="table"}). There was no significant difference in adhesion formation between groups C1 and C2 (P\>0.05).

Histopathological findings
--------------------------

In group A, the dissected surface of the serosa might be unrepaired with discontinuous mesothelial cells ([Figure 1](#f01){ref-type="fig"}). Capillary and fibroblastic proliferation, dense collagen fibers, and infiltration of large numbers of granulocytes and macrophages were observed. Compared with group A, group B exhibited milder histopathological changes ([Figure 2](#f02){ref-type="fig"}). The serosa had a partially repaired dissection surface with broken mesothelial cells. Capillary and fibroblastic proliferation, dense collagen fibers, and granulocyte and macrophage infiltration were still observed. In groups C1 and C2, the serosa had a repaired dissection surface with continuous mesothelial cells, and no obvious fibroblastic proliferation was found ([Figure 3](#f03){ref-type="fig"}). A little capillary proliferation, loose collagen fibers, and a small number of scattered granulocytes and macrophages were observed.

![Hematoxylin-eosin staining of the serosa in a representative rat in group A (untreated). The serosa has an unrepaired dissection surface with discontinuous mesothelial cells (black arrow). Capillary proliferation (green arrow), fibroblastic proliferation (red arrow), dense collagen fibers (yellow arrow), and infiltration of a large number of granulocytes and macrophages (white arrows) were observed (100×).](1414-431X-bjmbr-48-04-00344-gf001){#f01}

![Hematoxylin-eosin staining of the serosa in a representative rat in group B (treated with sodium carboxymethyl cellulose \[SCMC\] only). The serosa has a partially repaired dissection surface with broken mesothelial cells (black arrow). Capillary proliferation (green arrows), fibroblastic proliferation (red arrow), dense collagen fibers (yellow arrow), and infiltration of granulocytes and macrophages (white arrow) were observed (100×).](1414-431X-bjmbr-48-04-00344-gf002){#f02}

![Hematoxylin-eosin staining of the serosa in a representative rat in group C1 (treated with sodium carboxymethyl cellulose \[SCMC\] + 3 mg dexamethasone). The serosa has a repaired dissection surface with continuous mesothelial cells (black arrow). No obvious fibroblastic proliferation was found. Capillary proliferation (green arrow), loose collagen fibers (yellow arrow), and a small number of scattered granulocytes and macrophages (white arrow) were observed (100×).](1414-431X-bjmbr-48-04-00344-gf003){#f03}

Discussion
==========

We have developed a gel-like bioabsorbable SCMC in the form of a gel-like liquid with high fluidity that uniformly distributes in each part of the abdominal cavity, thus producing complete and extensive separation between peritonea. We found that 3 mg dexamethasone thoroughly mixed with SCMC produced an excellent anti-adhesion effect in a rat model of peritoneal adhesion. Dexamethasone in combination with SCMC significantly decreased the range, extent, and intensity of adhesions compared with SCMC alone. However, we did not find any difference in adhesion formation between groups C1 (3 mg dexamethasone + SCMC) and C2 (8 mg dexamethasone + SCMC), suggesting that the higher dose of dexamethasone did not prevent adhesion formation to a greater degree than the lower dose. In addition, 4 rats in group C2 exhibited delayed wound healing that was not evident in any of the other groups, implying that 8 mg dexamethasone may delay wound healing. Therefore, of the two doses tested in this study, 3 mg is more efficacious in preventing adhesion formation and avoiding potential side effects.

It was previously reported that adhesions in this model were easily separated at postoperative days 1-3 but more difficult to dissect at postoperative day 7 ([@B24]). Intestinal dilation, edema, and congestion were observed in the intestine proximal to adhesions, while the intestine distal to adhesions was normal. Electron microscopy inspection showed that at postoperative day 1, when adhesions began to form, the adhesion tissues mainly consisted of fibrin exuded in the acute phase of inflammation and a large number of neutrophils (G.H. Liu, unpublished data). Lymphocytes, plasma cells, and macrophages were rarely found. In the present study, we found that at postoperative days 3-5, neutrophils gradually decreased, accompanied by an increase in macrophages. Fibroblast proliferation and differentiation were observed. At postoperative days 5-7, the meshwork originally formed by fibrin was replaced by bundles of coarse collagen fibers. The numbers of macrophages and fibroblasts increased many-fold and were arranged parallel with the collagen fibers. Thus, the most crucial time for adhesion formation was at postoperative day 7. If the inserted barrier can last for 1 week, the damaged peritoneum will regenerate to prevent adhesion formation. However, in the present study, SCMC without dexamethasone was degraded and completely reabsorbed by postoperative day 5 (G.H. Liu, unpublished data), resulting in poor prevention of adhesion formation.

Combining SCMC and dexamethasone utilizes the advantages of both to reduce adhesion formation, including dexamethasone\'s pharmacological effects in reducing inflammatory exudation and inhibiting capillary and fibroblast proliferation. In this study, we mixed dexamethasone with a pre-prepared gel-like SCMC liquid. This allowed the mixture to become uniformly distributed throughout the abdominal cavity due to the bowel\'s movement and produced a complete and extensive separation between peritonea. In the present study at postoperative day 3, laparotomy examination revealed a small amount (approximately 2 mL) of exudate in the abdominal cavity. At postoperative day 7, the exudate was absorbed, and a transparent gel-like SCMC membrane (approximately 1 cm thick) was formed on the surface of the lesions between the abdominal wall and the intestine, and between the intestines. At postoperative day 9, there were some residual transparent gel-like SCMC membranes on the lesion surfaces. At postoperative day 12, the injured serosae were almost fully repaired. Loose adhesions were occasionally observed on the surface of lesions between the abdominal wall and the intestine. No intestinal dilations, edema, or congestion were found, and the color of the intestine was normal. Therefore, the degradation and complete reabsorption of SCMC required more than 7 days.

In conclusion, SCMC in combination with dexamethasone can prevent adhesion formation, inhibit migration of cells including inflammatory cells, reduce fibroblast viability and proliferation, prevent fibrin deposition on the serosal surface, and form a protective membrane on the serosal surface. SCMC in combination with dexamethasone does not irritate the mucosa or affect bowel movements. The safety and feasibility of SCMC in combination with dexamethasone to prevent adhesion formation after abdominal surgery warrants further clinical study.
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